Healthpeak Properties (NYSE:DOC) Updates FY24 Earnings Guidance

Healthpeak Properties (NYSE:DOC) updated its FY24 earnings guidance on Thursday. The company provided EPS guidance of $1.79-1.81 for the period, compared to the consensus estimate of $1.79. Healthpeak Properties also updated its FY 2024 guidance to 1.560-1.580 EPS.

Healthpeak Properties Price Performance

DOC stock opened at $22.29 on Friday. The company has a market capitalization of $15.59 billion, a P/E ratio of 47.43, a PEG ratio of 3.30 and a beta of 1.14. The company has a fifty day moving average price of $22.26 and a 200-day moving average price of $20.67. The company has a debt-to-equity ratio of 0.91, a quick ratio of 0.70 and a current ratio of 0.70. Healthpeak Properties has a 52-week low of $15.24 and a 52-week high of $23.26.

Healthpeak Properties (NYSE:DOC) last posted its quarterly earnings data on Thursday, July 25th. The real estate investment trust reported $0.21 EPS for the quarter, missing analysts’ consensus estimates of $0.44 by ($0.23). The company had revenue of $695.50 million during the quarter, compared to analyst estimates of $665.11 million. Healthpeak Properties had a return on equity of 3.51% and a net margin of 11.93%. Healthpeak Properties’s revenue was up 27.5% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.45 earnings per share. As a group, equities analysts expect that Healthpeak Properties will post 1.79 EPS for the current year.

Healthpeak Properties Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Monday, November 4th will be paid a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a yield of 5.38%. The ex-dividend date is Monday, November 4th. Healthpeak Properties’s dividend payout ratio is presently 255.32%.

Analyst Upgrades and Downgrades

Several research analysts have issued reports on the company. Wells Fargo & Company reiterated an “equal weight” rating and issued a $23.00 price target (up previously from $22.00) on shares of Healthpeak Properties in a report on Tuesday, October 1st. Evercore ISI increased their target price on Healthpeak Properties from $25.00 to $26.00 and gave the stock an “outperform” rating in a report on Monday, September 16th. Wedbush lifted their price target on shares of Healthpeak Properties from $22.00 to $25.00 and gave the company an “outperform” rating in a research report on Monday, July 29th. StockNews.com downgraded shares of Healthpeak Properties from a “hold” rating to a “sell” rating in a report on Saturday, October 19th. Finally, Deutsche Bank Aktiengesellschaft raised shares of Healthpeak Properties from a “hold” rating to a “buy” rating and raised their price objective for the company from $20.00 to $28.00 in a research note on Monday, October 21st. One investment analyst has rated the stock with a sell rating, five have issued a hold rating, nine have issued a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $22.62.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.